# QuadraMune(TM) for Prevention of COVID-19

> **NCT04421391** · NA · UNKNOWN · sponsor: **Therapeutic Solutions International** · enrollment: 500 (estimated)

## Conditions studied

- Covid19
- Coronavirus
- SARS-CoV 2

## Interventions

- **DIETARY_SUPPLEMENT:** QuadraMune(TM)

## Key facts

- **NCT ID:** NCT04421391
- **Lead sponsor:** Therapeutic Solutions International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-08
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-11-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04421391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04421391, "QuadraMune(TM) for Prevention of COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04421391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*